Edition:
India

Jaguar Health Inc (JAGX.OQ)

JAGX.OQ on NASDAQ Stock Exchange Capital Market

0.18USD
17 Nov 2017
Change (% chg)

$-0.00 (-1.64%)
Prev Close
$0.18
Open
$0.17
Day's High
$0.18
Day's Low
$0.17
Volume
625,413
Avg. Vol
326,665
52-wk High
$1.53
52-wk Low
$0.11

Latest Key Developments (Source: Significant Developments)

Jaguar Health ‍signs non-binding term sheet to issue note to Iliad Research
Wednesday, 8 Nov 2017 

Nov 8 (Reuters) - Jaguar Health Inc :Jaguar health enters non-binding agreement of terms to issue a secured convertible note to iliad research and trading, l.p. (an affiliate of chicago venture partners, l.p.), as jaguar expands commercial efforts for mytesi.Jaguar health inc - ‍signed a non-binding term sheet to issue to iliad research and trading, l.p. Note of $1,375,000 for purchase price of $1,100,000​.Jaguar health inc - ‍note will bear interest at rate of 8.0% per annum, with a fixed conversion price of $0.52/share​.Jaguar health inc - ‍note will be due nine months after its issue date​.  Full Article

Jaguar Health files for resale or other disposition of up to 36 million shares of co
Saturday, 21 Oct 2017 

Oct 20 (Reuters) - Jaguar Health Inc ::Jaguar Health files for resale or other disposition of up to 36 million shares of co by the selling shareholders ‍​.  Full Article

Jaguar Animal Health and Henry Schein sign distribution deal
Monday, 12 Dec 2016 

Jaguar Animal Health Inc : Jaguar Animal Health and Henry Schein, Inc. Sign exclusive distribution agreement for neonorm foal . Jaguar Animal Health inc - agreement became effective on december 9, 2016 .Press release - Jaguar Animal Health and Henry Schein, inc. Sign exclusive distribution agreement for neonorm foal.  Full Article

Jaguar Animal Health and Napo Pharmaceuticals announce details for proposed merger
Thursday, 6 Oct 2016 

Jaguar Animal Health Inc : Jaguar Animal Health and Napo Pharmaceuticals announce details for proposed merger . Announcing that Aspire Capital Fund LLC purchased 348,601 shares of Jaguar common stock, at a price per share of $2.28 . As of October 1, 2016, Napo owned 22.6% of Jaguar's outstanding shares of common stock. . LOI contemplates a 3-to-1 Napo-to-Jaguar value ratio .LOI also outlines capitalization requirements that napo would be required to satisfy to proceed with a potential merger.  Full Article

Jaguar Animal Health reports positive data on Neonorm botanical extract
Monday, 25 Jul 2016 

Jaguar Animal Health Inc : Has entered into negotiations for potential exclusive distribution relationship for pigs and dairy cattle in chinese market .Jaguar animal health announces positive preliminary topline results of two chinese-sponsored farm studies to evaluate the safety and effectiveness of neonorm botanical extract in piglets.  Full Article

Jaguar Animal Health files for sale of up to 3 mln shares by Aspire Capital Fund
Thursday, 23 Jun 2016 

Jaguar Animal Health Inc :Files for sale of up to 3 million shares of common stock by Aspire Capital Fund, LLC- SEC Filing.  Full Article

Jaguar Animal Health Inc Initiates Pivotal Field Study to Evaluate Safety and Effectiveness of Canalevia Drug Product Candidate
Tuesday, 22 Dec 2015 

Jaguar Animal Health Inc:Initiated a pivotal clinical field study to evaluate the safety and effectiveness of Canalevia, the Company's lead prescription drug product candidate for the treatment of acute diarrhea in dogs.  Full Article

Jaguar Animal Health Inc appoints Karen Wright as Chief Financial Officer
Thursday, 17 Dec 2015 

Jaguar Animal Health Inc:Says appointment of Karen Wright as chief financial officer, effective immediately.John Kallassy, Jaguar's former CFO, will continue to serve the Company as chief operating officer.  Full Article

BRIEF-Jaguar Health ‍signs non-binding term sheet to issue note to Iliad Research

* Jaguar health enters non-binding agreement of terms to issue a secured convertible note to iliad research and trading, l.p. (an affiliate of chicago venture partners, l.p.), as jaguar expands commercial efforts for mytesi